Status:

COMPLETED

The SCCS Polypill Pilot Trial

Lead Sponsor:

Vanderbilt University

Conditions:

Hypertension

Hyperlipidemia

Eligibility:

All Genders

45-75 years

Phase:

PHASE2

Brief Summary

In this study the investigators will examine the effect of the polypill on medication adherence, systolic blood pressure, and LDL cholesterol over a 12 month span.

Detailed Description

The purpose of this study is to assess if a polypill-based approach to primary CVD prevention is feasible in a low socioeconomic status population. The study will assess whether a polypill approach is...

Eligibility Criteria

Inclusion

  • Enrolled at the SCCS site in Mobile, Alabama, obtain care at Franklin Primary Health Center, or live in the surrounding area.
  • Aged 45-75 years
  • Baseline systolic blood pressure ≥120 mm Hg. In this open-label trial, the study physicians are permitted to prescribe any additional medication deemed appropriate to achieve blood pressure control.

Exclusion

  • History of coronary heart disease or stroke
  • History of cancer, except for basal cell skin cancer
  • History of liver disease, not including chronic, clinically-stable hepatitis
  • Laboratory evidence of hepatic dysfunction (an alanine aminotransferase level more than two times the upper limit of the normal range)
  • Known renal disease, estimated creatinine clearance \< 60
  • Current use of more than 2 anti-hypertensive medications
  • LDL cholesterol ≥190 mg/dl
  • Insulin-dependent diabetes
  • Known intolerance to any of the components of the polypill
  • Potassium \<3.4 or \>5.5 mEq/L
  • Use of medications that interact with statins, including those affecting the cytochrome P450 system
  • Current use of diuretics for indications other than hypertension
  • Comorbidities that might be expected to limit lifespan during the 12-month follow-up period
  • Inability to provide consent.

Key Trial Info

Start Date :

December 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 27 2018

Estimated Enrollment :

303 Patients enrolled

Trial Details

Trial ID

NCT02278471

Start Date

December 1 2015

End Date

June 27 2018

Last Update

May 14 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Franklin Primary Health Center

Mobile, Alabama, United States, 36603